RARE
Ultragenyx Pharmaceutical Inc.
NASDAQ · USHealthcareBiotechnology
$28.53-2.56%
Price as of Jul 20, 2026
RARE valuation
Ultragenyx Pharmaceutical Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 33.78x
- P/S forward
- 3.32x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -11.91x
- Price / sales
- 4.20x
- Price / cash flow
- -5.66x
Enterprise value
- Enterprise value
- $3.6B
- EV / sales
- 5.38x
- EV / EBITDA
- -7.16x
- EV / EBIT
- -6.42x
- Market cap
- $2.8B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.